Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Miho Minami
Observed name:
M Minami
Institution:
Nagoya University
Observed institution:
Nagoya University
OpenAlex ID:
A5008097340
The mTOR inhibitor, everolimus (RAD001), overcomes resistance to imatinib in quiescent Ph-positive acute lymphoblastic leukemia cells
2011
·
Y Kuwatsuka
, M Minami
, et al.
·
Blood Cancer Journal
·
16
PDF
Retention of CD34+ CML stem/progenitor cells during imatinib treatment and rapid decline after treatment with second-generation BCR–ABL inhibitors
2012
·
Y Minami
, A Abe
, et al.
·
Leukemia
·
8
PDF
Treatment with mTOR Inhibitor, Everolimus (RAD001) Overcomes Resistance to Imatinib in Ph-Leukemia Quiescent or T315I-Mutated Cells.
2009
·
Yosuke Minami
, Miho Minami
, et al.
·
Blood
·
3
Treatment with mTOR Inhibitor, Everolimus (RAD001) Overcomes Resistance to Imatinib In Ph-Leukemia Quiescent Cells.
2010
·
Yachiyo Kuwatsuka
, Yosuke Minami
, et al.
·
Blood
·
1
Retention of Slow-Cycling CD34+ cells During Imatinib Treatment and Rapid Decline After 2nd ABL-TKI Treatment in Ph+ Leukemia Cells
2011
·
Yosuke Minami
, Akihiro Abe
, et al.
·
Blood
Treatment with the PI3K/mTOR Inhibitor, NVP-BEZ235, Overcomes Resistance to Imatinib in Quiescent or T315I-Mutated Ph+ Leukemia Cells,
2011
·
Yosuke Minami
, Miho Minami
, et al.
·
Blood
Rapid Reduction of Chronic Myeloid Leukemia Stem Cells After Treatment with Second-Generation BCR-ABL Kinase Inhibitors, Dasatinib and Nilotinib
2010
·
Yosuke Minami
, Akihiro Abe
, et al.
·
Blood
Biomarkers In Cell Death of Imatinib-Resistant Ph-Leukemia Cells During Treatment with mTOR Inhibitor, Everolimus
2010
·
Miho Minami
, Yosuke Minami
, et al.
·
Blood
Treatment with Bortezomib Overcomes Resistance to Imatinib in Ph-Leukemia Quiescent Cells.
2009
·
Yachiyo Kuwatsuka
, Yosuke Minami
, et al.
·
Blood
Show more works
View as search
Works count:
9
Citation count:
28
H-index:
3
I10-index:
1
Year
Topic
Type
